BR112013009679B1 - uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação - Google Patents

uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação Download PDF

Info

Publication number
BR112013009679B1
BR112013009679B1 BR112013009679-9A BR112013009679A BR112013009679B1 BR 112013009679 B1 BR112013009679 B1 BR 112013009679B1 BR 112013009679 A BR112013009679 A BR 112013009679A BR 112013009679 B1 BR112013009679 B1 BR 112013009679B1
Authority
BR
Brazil
Prior art keywords
peptide
fsy
fty
sequence
food
Prior art date
Application number
BR112013009679-9A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112013009679A2 (pt
Inventor
Jaran Rauo
Original Assignee
Marealis As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marealis As filed Critical Marealis As
Publication of BR112013009679A2 publication Critical patent/BR112013009679A2/pt
Publication of BR112013009679B1 publication Critical patent/BR112013009679B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Animal Husbandry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112013009679-9A 2010-10-26 2011-07-13 uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação BR112013009679B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1018125.3 2010-10-26
GBGB1018125.3A GB201018125D0 (en) 2010-10-26 2010-10-26 Peptide
PCT/GB2011/051314 WO2012056205A1 (en) 2010-10-26 2011-07-13 Peptide

Publications (2)

Publication Number Publication Date
BR112013009679A2 BR112013009679A2 (pt) 2016-07-12
BR112013009679B1 true BR112013009679B1 (pt) 2020-12-01

Family

ID=43365585

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013009679-9A BR112013009679B1 (pt) 2010-10-26 2011-07-13 uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação

Country Status (11)

Country Link
US (2) US9044511B2 (cg-RX-API-DMAC7.html)
EP (1) EP2632937B8 (cg-RX-API-DMAC7.html)
JP (1) JP5879356B2 (cg-RX-API-DMAC7.html)
CN (1) CN103249741B (cg-RX-API-DMAC7.html)
AU (1) AU2011322287B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013009679B1 (cg-RX-API-DMAC7.html)
CA (1) CA2856153C (cg-RX-API-DMAC7.html)
DK (1) DK2632937T3 (cg-RX-API-DMAC7.html)
GB (1) GB201018125D0 (cg-RX-API-DMAC7.html)
RU (1) RU2572623C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012056205A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107337711A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Pro‑Hyp及应用和药物组合物
CN107325153A (zh) * 2017-07-26 2017-11-07 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Hyp‑Pro及应用和药物组合物
JPWO2021059840A1 (ja) * 2019-09-27 2021-10-07 太陽化学株式会社 アンジオテンシン変換酵素阻害剤
TWI890506B (zh) * 2024-06-27 2025-07-11 開曼群島商味丹國際(控股)有限公司 具有抑制ace活性之胜肽及其組合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455303A (en) * 1983-05-24 1984-06-19 The General Hospital Corporation Renin inhibitors
US5545719A (en) 1990-05-01 1996-08-13 Neuromedica, Inc. Nerve growth peptides
RU2084458C1 (ru) * 1993-05-27 1997-07-20 Институт высокомолекулярных соединений РАН Декапептид, обладающий противоопухолевой активностью
EP3167935B1 (en) 2003-05-01 2018-07-18 Cornell Research Foundation, Inc. Method and carrier complexes for delivering molecules to cells
WO2005007090A2 (en) * 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
WO2004056851A1 (en) 2003-07-31 2004-07-08 Franco Felici Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response
AT502292B1 (de) * 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
WO2007004869A2 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
HUP0600814A3 (en) * 2006-10-27 2009-08-28 Biostatin Gyogyszerkutato Fejl Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
CN101092450A (zh) * 2007-01-10 2007-12-26 中国人民解放军第三军医大学第一附属医院 与人mhc-ⅰ类分子结合的肝素酶多肽表位
EP2712620A1 (en) * 2008-02-07 2014-04-02 Cornell University Methods for Preventing or Treating Insulin Resistance
FR2943346B1 (fr) 2009-03-19 2011-05-06 Univ Paris Curie Peptides modulant l'activite de l'igf-1 et leurs applications
GB201008462D0 (en) 2010-05-20 2010-07-07 Marealis As Process

Also Published As

Publication number Publication date
EP2632937B8 (en) 2016-06-22
EP2632937A1 (en) 2013-09-04
EP2632937B1 (en) 2016-03-16
AU2011322287A1 (en) 2013-05-02
CA2856153A1 (en) 2012-05-03
RU2572623C2 (ru) 2016-01-20
JP2014500245A (ja) 2014-01-09
JP5879356B2 (ja) 2016-03-08
US20130281358A1 (en) 2013-10-24
AU2011322287B2 (en) 2015-06-25
CN103249741A (zh) 2013-08-14
WO2012056205A1 (en) 2012-05-03
CN103249741B (zh) 2015-12-02
US9044511B2 (en) 2015-06-02
RU2013124991A (ru) 2014-12-10
DK2632937T3 (en) 2016-05-30
CA2856153C (en) 2019-04-16
BR112013009679A2 (pt) 2016-07-12
GB201018125D0 (en) 2010-12-08
US20150315236A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
Lin et al. Angiotensin-I-converting enzyme (ACE)-inhibitory and antihypertensive properties of squid skin gelatin hydrolysates
Muguruma et al. Identification of pro-drug type ACE inhibitory peptide sourced from porcine myosin B: Evaluation of its antihypertensive effects in vivo
Ko et al. Angiotensin I-converting enzyme inhibitory peptides from an enzymatic hydrolysate of flounder fish (Paralichthys olivaceus) muscle as a potent anti-hypertensive agent
Manikkam et al. A review of potential marine-derived hypotensive and anti-obesity peptides
Saleh et al. Recent research in antihypertensive activity of food protein-derived hydrolyzates and peptides
KR101533308B1 (ko) 안지오텐신-i 전환 효소 저해능을 나타내는 펩타이드를 유효성분으로 포함하는 심혈관계 질환 예방 또는 치료용 약학적 조성물
WO2010125192A1 (en) Use of a casein-derived peptide and compositions thereof as antihypertensive
KR102265501B1 (ko) 다중구리 산화효소 펩타이드를 포함하는 구리대사 관련 신경계 질환의 예방 또는 치료용 조성물
US9044511B2 (en) Peptide
Tuz et al. Purification of Mucuna pruriens (L) peptide fractions and evaluation of their ACE inhibitory effect
KR101918239B1 (ko) 괭생이 모자반 가수분해물을 유효성분으로 함유하는 고혈압 예방 또는 치료용 약학적 조성물
ES2328835T3 (es) Hidrolizado de proteinas con efecto antidiabetico.
KR20250137070A (ko) 신규한 아밀린 호르몬 변이 펩타이드 및 이의 용도
JP2004099447A (ja) コレステロール低減化ペプチド
KR102882938B1 (ko) 흰점박이 꽃무지 유충 가수분해물 유래의 펩타이드를 유효성분으로 포함하는 항고혈압 식품 조성물
KR101404850B1 (ko) 클로렐라 유래 항고혈압 활성을 갖는 펩티드
WO2014030977A1 (ko) 안지오텐신-i 전환 효소 저해능을 나타내는 펩타이드를 유효성분으로 포함하는 심혈관계 질환 예방 또는 치료용 약학적 조성물
CN109937048A (zh) 用2-单酰甘油分解酶的肝脂肪变性或非酒精性脂肪肝的治疗方法
KR20120021590A (ko) 틸라피아 비늘의 효소적 가수분해물을 유효성분으로 포함하는 고혈압의 예방 또는 치료용 약학적 조성물
BRPI0809319A2 (pt) Agente para suprimir espessamento de parede de coração, agente profilático para hipertrofia cardíaca, agente profilático para insuficiência cardíaca, e, alimento funcional
KR20110087416A (ko) 꽁치 가수분해물을 포함하는 고혈압 예방 또는 개선용 조성물
Poddar In Vitro Antihypertensive Potentials of Extensively Hydrolyzed Peanut Protein Concentrate
KR20250017027A (ko) Ccl8 결합 펩타이드를 포함하는 vegf 유도-혈관신생 억제용 조성물.
KR20260070060A (ko) 성게 유래 펩타이드 및 이의 용도
EP3170507B1 (en) Antihypertensive peptides from olive oil

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25G Requested change of headquarter approved

Owner name: MAREALIS AS (NO)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/07/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2840 DE 10-06-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.